Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct spatiotemporal atrophy patterns in corticobasal syndrome are associated with different underlying pathologies.

medRxiv : the preprint server for health sciences·2024
Same author

Sexually dimorphic differences in angiogenesis markers predict brain aging trajectories.

bioRxiv : the preprint server for biology·2023
Same author

LGI1 antibody encephalitis: acute treatment comparisons and outcome.

Journal of neurology, neurosurgery, and psychiatry·2021
Same author

Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2020
Same author

Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2020
Same author

Dopamine receptor D<sub>4</sub> (DRD<sub>4</sub>) polymorphisms with reduced functional potency intensify atrophy in syndrome-specific sites of frontotemporal dementia.

NeuroImage. Clinical·2019

Related Experiment Video

Updated: Jun 4, 2026

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

An algorithm for genetic testing of frontotemporal lobar degeneration.

J S Goldman1, R Rademakers, E D Huey

  • 1Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, 630 W. 168th St., Box 16, New York, NY 10032, USA. jg2673@columbia.edu

Neurology
|February 2, 2011
PubMed
Summary

This study presents an algorithm to guide genetic testing for frontotemporal lobar degeneration (FTLD). It helps clinicians determine if genetic testing is needed and in what order, based on patient presentation and family history.

More Related Videos

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Related Experiment Videos

Last Updated: Jun 4, 2026

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

Published on: February 12, 2015

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Area of Science:

  • Neuroscience
  • Genetics
  • Pathology

Background:

  • Frontotemporal lobar degeneration (FTLD) is a group of progressive neurodegenerative disorders.
  • Accurate genetic diagnosis is crucial for understanding FTLD subtypes and prognosis.
  • Clinical and pathological heterogeneity complicates genetic testing decisions.

Purpose of the Study:

  • To develop a clinical algorithm for guiding genetic testing in patients with FTLD.
  • To integrate clinical, neuroimaging, pathological, and family history data into a decision-making framework.
  • To optimize the selection and sequencing of genetic tests for FTLD.

Main Methods:

  • Comprehensive literature search on FTLD genes, phenotypes, and family history.
  • Systematic review of clinical and pathological features associated with known FTLD-related genes.
  • Development of a decision-making algorithm based on synthesized literature data.

Main Results:

  • An algorithm was derived to assist clinicians in FTLD genetic testing decisions.
  • The algorithm utilizes clinical presentation, neuroimaging, family history, and autopsy findings.
  • It provides guidance on the necessity and order of genetic tests.

Conclusions:

  • Advances in FTLD genetics, pathology, and imaging facilitate informed testing strategies.
  • The developed algorithm empowers clinicians to make evidence-based genetic testing choices for FTLD patients.
  • Integrating diverse data points improves diagnostic yield and patient management.